Cargando…

Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents

Fascin is an actin binding and bundling protein that is not expressed in normal epithelial tissues but overexpressed in a variety of invasive epithelial tumors. It has a critical role in cancer cell metastasis by promoting cell migration and invasion. Here we report the crystal structures of fascin...

Descripción completa

Detalles Bibliográficos
Autores principales: Francis, Stuart, Croft, Daniel, Schüttelkopf, Alexander W., Parry, Charles, Pugliese, Angelo, Cameron, Ken, Claydon, Sophie, Drysdale, Martin, Gardner, Claire, Gohlke, Andrea, Goodwin, Gillian, Gray, Christopher H., Konczal, Jennifer, McDonald, Laura, Mezna, Mokdad, Pannifer, Andrew, Paul, Nikki R., Machesky, Laura, McKinnon, Heather, Bower, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419574/
https://www.ncbi.nlm.nih.gov/pubmed/30773430
http://dx.doi.org/10.1016/j.bmcl.2019.01.035
_version_ 1783403973445681152
author Francis, Stuart
Croft, Daniel
Schüttelkopf, Alexander W.
Parry, Charles
Pugliese, Angelo
Cameron, Ken
Claydon, Sophie
Drysdale, Martin
Gardner, Claire
Gohlke, Andrea
Goodwin, Gillian
Gray, Christopher H.
Konczal, Jennifer
McDonald, Laura
Mezna, Mokdad
Pannifer, Andrew
Paul, Nikki R.
Machesky, Laura
McKinnon, Heather
Bower, Justin
author_facet Francis, Stuart
Croft, Daniel
Schüttelkopf, Alexander W.
Parry, Charles
Pugliese, Angelo
Cameron, Ken
Claydon, Sophie
Drysdale, Martin
Gardner, Claire
Gohlke, Andrea
Goodwin, Gillian
Gray, Christopher H.
Konczal, Jennifer
McDonald, Laura
Mezna, Mokdad
Pannifer, Andrew
Paul, Nikki R.
Machesky, Laura
McKinnon, Heather
Bower, Justin
author_sort Francis, Stuart
collection PubMed
description Fascin is an actin binding and bundling protein that is not expressed in normal epithelial tissues but overexpressed in a variety of invasive epithelial tumors. It has a critical role in cancer cell metastasis by promoting cell migration and invasion. Here we report the crystal structures of fascin in complex with a series of novel and potent inhibitors. Structure-based elaboration of these compounds enabled the development of a series with nanomolar affinities for fascin, good physicochemical properties and the ability to inhibit fascin-mediated bundling of filamentous actin. These compounds provide promising starting points for fascin-targeted anti-metastatic therapies.
format Online
Article
Text
id pubmed-6419574
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier Science Ltd
record_format MEDLINE/PubMed
spelling pubmed-64195742019-04-15 Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents Francis, Stuart Croft, Daniel Schüttelkopf, Alexander W. Parry, Charles Pugliese, Angelo Cameron, Ken Claydon, Sophie Drysdale, Martin Gardner, Claire Gohlke, Andrea Goodwin, Gillian Gray, Christopher H. Konczal, Jennifer McDonald, Laura Mezna, Mokdad Pannifer, Andrew Paul, Nikki R. Machesky, Laura McKinnon, Heather Bower, Justin Bioorg Med Chem Lett Article Fascin is an actin binding and bundling protein that is not expressed in normal epithelial tissues but overexpressed in a variety of invasive epithelial tumors. It has a critical role in cancer cell metastasis by promoting cell migration and invasion. Here we report the crystal structures of fascin in complex with a series of novel and potent inhibitors. Structure-based elaboration of these compounds enabled the development of a series with nanomolar affinities for fascin, good physicochemical properties and the ability to inhibit fascin-mediated bundling of filamentous actin. These compounds provide promising starting points for fascin-targeted anti-metastatic therapies. Elsevier Science Ltd 2019-04-15 /pmc/articles/PMC6419574/ /pubmed/30773430 http://dx.doi.org/10.1016/j.bmcl.2019.01.035 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Francis, Stuart
Croft, Daniel
Schüttelkopf, Alexander W.
Parry, Charles
Pugliese, Angelo
Cameron, Ken
Claydon, Sophie
Drysdale, Martin
Gardner, Claire
Gohlke, Andrea
Goodwin, Gillian
Gray, Christopher H.
Konczal, Jennifer
McDonald, Laura
Mezna, Mokdad
Pannifer, Andrew
Paul, Nikki R.
Machesky, Laura
McKinnon, Heather
Bower, Justin
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents
title Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents
title_full Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents
title_fullStr Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents
title_full_unstemmed Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents
title_short Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents
title_sort structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419574/
https://www.ncbi.nlm.nih.gov/pubmed/30773430
http://dx.doi.org/10.1016/j.bmcl.2019.01.035
work_keys_str_mv AT francisstuart structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT croftdaniel structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT schuttelkopfalexanderw structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT parrycharles structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT puglieseangelo structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT cameronken structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT claydonsophie structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT drysdalemartin structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT gardnerclaire structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT gohlkeandrea structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT goodwingillian structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT graychristopherh structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT konczaljennifer structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT mcdonaldlaura structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT meznamokdad structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT panniferandrew structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT paulnikkir structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT macheskylaura structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT mckinnonheather structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents
AT bowerjustin structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents